Jung Hoon, Choi Eun Kyung, Baek Seung Ik, Cho Changhee, Jin Yehun, Kwak Kyung Hwa, Jeon Younghoon, Park Sung-Sik, Kim Sioh, Lim Dong Gun
Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.
Dose Response. 2019 May 28;17(2):1559325819853651. doi: 10.1177/1559325819853651. eCollection 2019 Apr-Jun.
Although remote ischemic preconditioning (RIPC) is an organ-protective maneuver from subsequent ischemia reperfusion injury (IRI) by application of brief ischemia and reperfusion to other organs, its mechanism remains unclear. However, it is known that RIPC reduces the heart, brain, and liver IRI, and that nitric oxide (NO) is involved in the mechanism of this effect. To identify the role of NO in the protective effect of RIPC in renal IRI, this study examined renal function, oxidative status, and histopathological changes using N-nitro-L-arginine methyl ester (L-NAME), an NO synthase inhibitor. . Blood urea nitrogen, creatinine (Cr), and renal tissue malondialdehyde levels were lower, histopathological damage was less severe, and superoxide dismutase level was higher in the RIPC + IRI group than in the IRI group. Obtained results suggest that RIPC before renal IRI contributes to improvement of renal function, increases antioxidative marker levels, and decreases oxidative stress marker levels and histopathological damage. Moreover, NO is likely to play an important role in this protective effect of RIPC on renal IRI.
尽管远程缺血预处理(RIPC)是一种通过对其他器官施加短暂缺血和再灌注来预防后续缺血再灌注损伤(IRI)的器官保护措施,但其机制仍不清楚。然而,已知RIPC可减轻心脏、大脑和肝脏的IRI,并且一氧化氮(NO)参与了这一效应的机制。为了确定NO在RIPC对肾IRI的保护作用中的作用,本研究使用NO合酶抑制剂N-硝基-L-精氨酸甲酯(L-NAME)检测了肾功能、氧化状态和组织病理学变化。与IRI组相比,RIPC + IRI组的血尿素氮、肌酐(Cr)和肾组织丙二醛水平较低,组织病理学损伤较轻,超氧化物歧化酶水平较高。所得结果表明,肾IRI前的RIPC有助于改善肾功能,提高抗氧化标志物水平,降低氧化应激标志物水平和组织病理学损伤。此外,NO可能在RIPC对肾IRI的这种保护作用中发挥重要作用。